Description: This report examines lapse experience on individual disability income insurance products by various policyholder and product factors. The study can be used for industry benchmarking as well as for background information for product development and planning purposes.

Description: This report explores the adoption and impact of artificial intelligence and large language models in the Greater China insurance industry, drawing from surveys and case studies.

Description: This paper helps the audience understand the actuary’s role in estimating the financial impact of primary care programs. In addition, the paper can be used by actuaries to think about key issues when estimating the financial impact of their employers’ and clients’ own primary care programs.

Description: Electronic Health Records, or EHRs, are a major worldwide initiative to eliminate paper recordings – including Attending Physician Statements (APSs) – of an individual’s medical history and current treatment.

Description: The Health Care Cost Institute (HCCI) recently released their annual health care cost and utilization report on February 13, 2020. This report illustrates employer group commercial health care costs and trends from 2014 – 2018.

Description: This report summarizes thoughts and questions about the impact of COVID-19 on working in retirement, phased retirement and how the definition and timing of retirement may change. It provides a synthesis of the expert input mentioned above and offers background on related research results. It also describes other issues for further consideration. T

Description: This study estimates the number of COVID-19 confirmed cases and reported deaths by hospital referral regions (HRR) using Johns Hopkins University COVID-19 data by U.S. county and the Dartmouth Atlas Project division of counties into HRRs.

Description: A comprehensive primer on long-term care wellness programs, their design, implementation, challenges, metrics for success, and emerging industry practices.

Description: The cost of prescription drugs is top of mind for consumers, payers and policymakers. Despite legislative efforts, such as the Inflation Reduction Act, the problem remains. More than 30% of all Americans say they have not taken prescription drugs as prescribed in the last 12 months because of the expense. The purpose of this paper is to discuss an alternative to policy solutions: reimagining pharmacy financing in the commercial space using a value-based reimbursement methodology that increases transparency, encourages competition, aligns stakeholder incentives and mitigates total cost of care (TCOC) increases. This paper will demonstrate that it is possible to implement such a methodology under the current infrastructure, but one can identify limitations.

Description: An in-depth analysis of the insurance landscape in China and seven key Asia Pacific Markets, focusing on the rapid development of critical illness products and the impact of technology on insurance purchasing behaviors.